天虹股份(002419.SZ):“招商創融-天虹(二期)資產支持專項計劃”尚未成立
格隆匯 9 月 18日丨天虹股份(002419.SZ)公佈,2020年8月17日,公司第二次臨時股東大會審議通過了《關於公司為“招商創融-天虹(二期)資產支持專項計劃”(“二期專項計劃”)提供增信措施並享有專項計劃優先收購權的議案》、《關於公司為控股股東向公司提供履約保證提供反擔保暨關聯交易的議案》等事項。
2020年9月17日,公司向招商證券資產管理有限公司出具了《二期專項計劃流動性支持承諾函》、《二期專項計劃之差額支付承諾函》,與其簽署了《二期專項計劃優先收購權協議》,並向中國航空技術深圳有限公司出具了《不可撤銷反擔保函》。截至目前,二期專項計劃尚未成立。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.